Literature DB >> 12845720

Preliminary study of the in vitro growth inhibition of human bladder cancer cell line BIU-87 by arsenic trioxide.

Q Tong1, F Zeng, Z Zhu, G Lu.   

Abstract

To study the effects of arsenic trioxide (As2O3) on the in vitro growth of human bladder cancer cells and the mechanisms. The growth inhibition rates of human bladder cancer cell line BIU-87 by various concentrations of As2O3 were detected by using MTT method. Cell apoptosis was detected by in situ terminally labeled transferase technique and bcl-2 gene expression of BIU-87 cells was observed by SABC immunohistochemical method. The results showed that As2O3 could inhibit the growth of BIU-87 effectively in a dose-dependent manner. After drug's action, the apoptotic bladder cancer cells were obviously increased, which depended on the prolongation of the action time and Bcl-2 expression of BIU-87 cells was decreased significantly. It was suggested that As2O3 could significantly inhibit the growth of bladder human cancer cells. Inducing cell apoptosis by down-regulating the expression of bcl-2 gene might be one of its action mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12845720     DOI: 10.1007/bf02887045

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  3 in total

1.  The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway.

Authors:  D Cortez; G Stoica; J H Pierce; A M Pendergast
Journal:  Oncogene       Date:  1996-12-19       Impact factor: 9.867

2.  Effects of arsenic on DNA synthesis in human lymphocytes.

Authors:  Z Meng
Journal:  Arch Environ Contam Toxicol       Date:  1993-11       Impact factor: 2.804

3.  In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.

Authors:  G Q Chen; J Zhu; X G Shi; J H Ni; H J Zhong; G Y Si; X L Jin; W Tang; X S Li; S M Xong; Z X Shen; G L Sun; J Ma; P Zhang; T D Zhang; C Gazin; T Naoe; S J Chen; Z Y Wang; Z Chen
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.